Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10956940 | Molecular and Cellular Neuroscience | 2005 | 10 Pages |
Abstract
Few diseases are characterized by high homocysteine (HCY) and low folate and vitamin B12 blood levels. Alzheimer disease (AD) is among these. It has already been shown that DNA methylation is involved in amyloid precursor protein (APP) processing and β-amyloid (Aβ) production through the regulation of Presenilin1 (PS1) expression and that exogenous S-adenosylmethionine (SAM) can silence the gene reducing Aβ production. Here we demonstrate that BACE (β-secretase), as well as PS1, is regulated by methylation and that the reduction of folate and vitamin B12 in culture medium can cause a reduction of SAM levels with consequent increase in presenilin1 and BACE levels and with increase in Aβ production. The simultaneous administration of SAM to the deficient medium can restore the normal gene expression, thus reducing the Aβ levels. The use of deprived medium was intended to mimic a mild nutritional deficit involved in the onset of AD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Andrea Fuso, Laura Seminara, Rosaria A. Cavallaro, Fabrizio D'Anselmi, Sigfrido Scarpa,